Novartis Investigative Site

Kasuga, Fukuoka 816-0864

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Atherosclerosis, Cardiovascular Disease, Pulmonary Disease, Chronic Obstructive, Type 2 Diabetes Mellitus

Studies at this site

• Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients — Completed
• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early
• A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early